InvestorsHub Logo
Followers 5
Posts 532
Boards Moderated 0
Alias Born 03/13/2017

Re: JellyDonut post# 4211

Friday, 09/15/2017 10:46:21 AM

Friday, September 15, 2017 10:46:21 AM

Post# of 30450
Plus way to much competition in this space!!! As well as this!!
The Food and Drug Administration (#FDA) is requesting interested persons to submit comments concerning abuse potential, actual abuse, #medicalusefulness, trafficking, and impact of scheduling changes on availability for medical use of 17 drug substances. One of which is #cannabidiol. These comments will be considered in preparing a response from the United States to the #WorldHealthOrganization (WHO) regarding the abuse liability and diversion of these drugs. WHO will use this information to consider whether to recommend that certain international restrictions be placed on these drugs. This notice requesting comments is required by the Controlled Substances Act (the #CSA). https://lnkd.in/gbYzWnv



Cannabidiol (CBD) is one of the active cannabinoids identified in cannabis. CBD has been shown to be beneficial in experimental models of several neurological disorders, including those of seizure and epilepsy. In the United States, CBD-containing products are in human clinical testing in three therapeutic areas, but no such products are approved by FDA for marketing for medical purposes in the United States. CBD is a Schedule I controlled substance under the CSA. At the 37th (2015) meeting of the ECDD, the committee requested that the Secretariat prepare relevant documentation to conduct pre-reviews for several substances, including CBD.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CANB News